Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation a randomized clinical trial

Flavia Indrio; Antonio Di Mauro; Giuseppe Riezzo; Elisa Civardi; Cristina Intini; Luigi Corvaglia; Elisa Ballardini; Massimo Bisceglia; Mauro Cinquetti; Emanuela Brazzoduro; Antonio Del Vecchio; Silvio Tafuri; Ruggiero Francavilla

doi:10.1001/jamapediatrics.2013.4367

Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation a randomized clinical trial

Flavia Indrio, Antonio Di Mauro, Giuseppe Riezzo, Elisa Civardi, Cristina Intini, Luigi Corvaglia, Elisa Ballardini, Massimo Bisceglia, Mauro Cinquetti, Emanuela Brazzoduro, Antonio Del Vecchio, Silvio Tafuri, Ruggiero Francavilla

Research output: Contribution to journal › Article › peer-review

Abstract

IMPORTANCE: Infantile colic, gastroesophageal reflux, and constipation are the most common functional gastrointestinal disorders that lead to referral to a pediatrician during the first 6 months of life and are often responsible for hospitalization, feeding changes, use of drugs, parental anxiety, and loss of parental working days with relevant social consequences. OBJECTIVE: To investigate whether oral supplementation with Lactobacillus reuteri DSM 17938 during the first 3 months of life can reduce the onset of colic, gastroesophageal reflux, and constipation in term newborns and thereby reduce the socioeconomic impact of these conditions. DESIGN: A prospective, multicenter, double-masked, placebo-controlled randomized clinical trial was performed on term newborns (age

Original language	English
Pages (from-to)	228-233
Number of pages	6
Journal	JAMA Pediatrics
Volume	168
Issue number	3
DOIs	https://doi.org/10.1001/jamapediatrics.2013.4367
Publication status	Published - Mar 2014

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health

Access to Document

10.1001/jamapediatrics.2013.4367

Cite this

Indrio, F., Di Mauro, A., Riezzo, G., Civardi, E., Intini, C., Corvaglia, L., Ballardini, E., Bisceglia, M., Cinquetti, M., Brazzoduro, E., Del Vecchio, A., Tafuri, S., & Francavilla, R. (2014). Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation a randomized clinical trial. JAMA Pediatrics, 168(3), 228-233. https://doi.org/10.1001/jamapediatrics.2013.4367

Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation a randomized clinical trial. / Indrio, Flavia; Di Mauro, Antonio; Riezzo, Giuseppe ; Civardi, Elisa; Intini, Cristina; Corvaglia, Luigi; Ballardini, Elisa; Bisceglia, Massimo; Cinquetti, Mauro; Brazzoduro, Emanuela; Del Vecchio, Antonio; Tafuri, Silvio; Francavilla, Ruggiero.

In: JAMA Pediatrics, Vol. 168, No. 3, 03.2014, p. 228-233.

Research output: Contribution to journal › Article › peer-review

Indrio, F, Di Mauro, A, Riezzo, G , Civardi, E, Intini, C, Corvaglia, L, Ballardini, E, Bisceglia, M, Cinquetti, M, Brazzoduro, E, Del Vecchio, A, Tafuri, S & Francavilla, R 2014, 'Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation a randomized clinical trial', JAMA Pediatrics, vol. 168, no. 3, pp. 228-233. https://doi.org/10.1001/jamapediatrics.2013.4367

Indrio, Flavia ; Di Mauro, Antonio ; Riezzo, Giuseppe ; Civardi, Elisa ; Intini, Cristina ; Corvaglia, Luigi ; Ballardini, Elisa ; Bisceglia, Massimo ; Cinquetti, Mauro ; Brazzoduro, Emanuela ; Del Vecchio, Antonio ; Tafuri, Silvio ; Francavilla, Ruggiero. / Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation a randomized clinical trial. In: JAMA Pediatrics. 2014 ; Vol. 168, No. 3. pp. 228-233.

@article{813d9a84edeb47cdbca32063f471766c,

title = "Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation a randomized clinical trial",

abstract = "IMPORTANCE: Infantile colic, gastroesophageal reflux, and constipation are the most common functional gastrointestinal disorders that lead to referral to a pediatrician during the first 6 months of life and are often responsible for hospitalization, feeding changes, use of drugs, parental anxiety, and loss of parental working days with relevant social consequences. OBJECTIVE: To investigate whether oral supplementation with Lactobacillus reuteri DSM 17938 during the first 3 months of life can reduce the onset of colic, gastroesophageal reflux, and constipation in term newborns and thereby reduce the socioeconomic impact of these conditions. DESIGN: A prospective, multicenter, double-masked, placebo-controlled randomized clinical trial was performed on term newborns (age ",

author = "Flavia Indrio and {Di Mauro}, Antonio and Giuseppe Riezzo and Elisa Civardi and Cristina Intini and Luigi Corvaglia and Elisa Ballardini and Massimo Bisceglia and Mauro Cinquetti and Emanuela Brazzoduro and {Del Vecchio}, Antonio and Silvio Tafuri and Ruggiero Francavilla",

year = "2014",

month = mar,

doi = "10.1001/jamapediatrics.2013.4367",

language = "English",

volume = "168",

pages = "228--233",

journal = "JAMA Pediatrics",

issn = "2168-6203",

publisher = "American Medical Association",

number = "3",

}

TY - JOUR

T1 - Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation a randomized clinical trial

AU - Indrio, Flavia

AU - Di Mauro, Antonio

AU - Riezzo, Giuseppe

AU - Civardi, Elisa

AU - Intini, Cristina

AU - Corvaglia, Luigi

AU - Ballardini, Elisa

AU - Bisceglia, Massimo

AU - Cinquetti, Mauro

AU - Brazzoduro, Emanuela

AU - Del Vecchio, Antonio

AU - Tafuri, Silvio

AU - Francavilla, Ruggiero

PY - 2014/3

Y1 - 2014/3

N2 - IMPORTANCE: Infantile colic, gastroesophageal reflux, and constipation are the most common functional gastrointestinal disorders that lead to referral to a pediatrician during the first 6 months of life and are often responsible for hospitalization, feeding changes, use of drugs, parental anxiety, and loss of parental working days with relevant social consequences. OBJECTIVE: To investigate whether oral supplementation with Lactobacillus reuteri DSM 17938 during the first 3 months of life can reduce the onset of colic, gastroesophageal reflux, and constipation in term newborns and thereby reduce the socioeconomic impact of these conditions. DESIGN: A prospective, multicenter, double-masked, placebo-controlled randomized clinical trial was performed on term newborns (age

AB - IMPORTANCE: Infantile colic, gastroesophageal reflux, and constipation are the most common functional gastrointestinal disorders that lead to referral to a pediatrician during the first 6 months of life and are often responsible for hospitalization, feeding changes, use of drugs, parental anxiety, and loss of parental working days with relevant social consequences. OBJECTIVE: To investigate whether oral supplementation with Lactobacillus reuteri DSM 17938 during the first 3 months of life can reduce the onset of colic, gastroesophageal reflux, and constipation in term newborns and thereby reduce the socioeconomic impact of these conditions. DESIGN: A prospective, multicenter, double-masked, placebo-controlled randomized clinical trial was performed on term newborns (age

UR - http://www.scopus.com/inward/record.url?scp=84896758037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896758037&partnerID=8YFLogxK

U2 - 10.1001/jamapediatrics.2013.4367

DO - 10.1001/jamapediatrics.2013.4367

M3 - Article

C2 - 24424513

AN - SCOPUS:84896758037

VL - 168

SP - 228

EP - 233

JO - JAMA Pediatrics

JF - JAMA Pediatrics

SN - 2168-6203

IS - 3

ER -

Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation a randomized clinical trial

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this